Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 98 | 2024 | 17564 | 5.290 |
Why?
|
Epidemics | 10 | 2024 | 517 | 2.840 |
Why?
|
Sexual Behavior | 17 | 2024 | 2200 | 2.060 |
Why?
|
Infectious Disease Transmission, Vertical | 12 | 2024 | 1359 | 1.960 |
Why?
|
Vaginal Discharge | 2 | 2024 | 25 | 1.810 |
Why?
|
Acquired Immunodeficiency Syndrome | 7 | 2024 | 2203 | 1.620 |
Why?
|
Africa South of the Sahara | 18 | 2024 | 750 | 1.410 |
Why?
|
Pregnancy Complications, Infectious | 9 | 2024 | 2181 | 1.290 |
Why?
|
Anti-Retroviral Agents | 13 | 2024 | 1794 | 1.280 |
Why?
|
Sexually Transmitted Diseases | 4 | 2024 | 666 | 1.260 |
Why?
|
Sexual Partners | 8 | 2024 | 806 | 1.220 |
Why?
|
Zimbabwe | 18 | 2020 | 135 | 1.160 |
Why?
|
Ulcer | 2 | 2024 | 204 | 1.030 |
Why?
|
Models, Statistical | 12 | 2024 | 5103 | 1.030 |
Why?
|
Models, Theoretical | 17 | 2024 | 3590 | 1.030 |
Why?
|
Anti-HIV Agents | 17 | 2024 | 4567 | 1.020 |
Why?
|
South Africa | 19 | 2024 | 1870 | 0.990 |
Why?
|
Prevalence | 36 | 2024 | 15880 | 0.990 |
Why?
|
Substance Abuse, Intravenous | 3 | 2024 | 530 | 0.950 |
Why?
|
Bayes Theorem | 12 | 2024 | 2358 | 0.820 |
Why?
|
Risk-Taking | 5 | 2024 | 1041 | 0.730 |
Why?
|
Malawi | 8 | 2024 | 308 | 0.730 |
Why?
|
Rural Health | 6 | 2017 | 300 | 0.660 |
Why?
|
Adolescent | 56 | 2024 | 89168 | 0.610 |
Why?
|
Prenatal Care | 9 | 2024 | 1159 | 0.610 |
Why?
|
HIV Seropositivity | 3 | 2023 | 963 | 0.590 |
Why?
|
Young Adult | 47 | 2024 | 60045 | 0.580 |
Why?
|
Sentinel Surveillance | 3 | 2019 | 292 | 0.580 |
Why?
|
Incidence | 25 | 2024 | 21552 | 0.560 |
Why?
|
CD4 Lymphocyte Count | 9 | 2021 | 2596 | 0.550 |
Why?
|
Adult | 69 | 2024 | 223542 | 0.530 |
Why?
|
Child, Orphaned | 3 | 2015 | 55 | 0.490 |
Why?
|
Health Policy | 6 | 2018 | 2699 | 0.490 |
Why?
|
Rural Population | 8 | 2021 | 2317 | 0.480 |
Why?
|
United Nations | 3 | 2019 | 150 | 0.460 |
Why?
|
Social Stigma | 2 | 2021 | 785 | 0.450 |
Why?
|
Female | 77 | 2024 | 396943 | 0.440 |
Why?
|
Humans | 113 | 2024 | 768451 | 0.440 |
Why?
|
Fertility | 2 | 2018 | 772 | 0.430 |
Why?
|
HIV | 4 | 2021 | 1596 | 0.420 |
Why?
|
Tuberculosis, Pulmonary | 2 | 2020 | 846 | 0.400 |
Why?
|
Herpes Genitalis | 1 | 2023 | 149 | 0.400 |
Why?
|
Mass Screening | 6 | 2019 | 5455 | 0.400 |
Why?
|
Perinatal Mortality | 1 | 2022 | 102 | 0.400 |
Why?
|
Pregnancy | 17 | 2024 | 30179 | 0.390 |
Why?
|
Circumcision, Male | 2 | 2020 | 149 | 0.390 |
Why?
|
Chlamydia Infections | 2 | 2024 | 365 | 0.390 |
Why?
|
Africa | 7 | 2024 | 726 | 0.390 |
Why?
|
Isoniazid | 2 | 2020 | 288 | 0.380 |
Why?
|
Tuberculosis | 4 | 2020 | 2030 | 0.380 |
Why?
|
Antitubercular Agents | 3 | 2020 | 1390 | 0.360 |
Why?
|
Health Surveys | 3 | 2021 | 4056 | 0.350 |
Why?
|
Kenya | 5 | 2023 | 757 | 0.350 |
Why?
|
Middle Aged | 47 | 2024 | 223418 | 0.340 |
Why?
|
Cost-Benefit Analysis | 6 | 2019 | 5532 | 0.340 |
Why?
|
Antiretroviral Therapy, Highly Active | 5 | 2019 | 1903 | 0.340 |
Why?
|
Homosexuality, Male | 4 | 2024 | 1345 | 0.340 |
Why?
|
HIV Seroprevalence | 1 | 2019 | 89 | 0.340 |
Why?
|
Male | 60 | 2024 | 364781 | 0.320 |
Why?
|
Vulnerable Populations | 3 | 2015 | 717 | 0.310 |
Why?
|
Mozambique | 2 | 2024 | 55 | 0.310 |
Why?
|
Stereotyping | 1 | 2020 | 243 | 0.310 |
Why?
|
Counseling | 4 | 2019 | 1548 | 0.300 |
Why?
|
Policy Making | 2 | 2019 | 545 | 0.300 |
Why?
|
Behavior | 1 | 2021 | 545 | 0.290 |
Why?
|
Quality-Adjusted Life Years | 4 | 2018 | 1734 | 0.290 |
Why?
|
Viral Load | 5 | 2019 | 3399 | 0.290 |
Why?
|
Population Density | 2 | 2024 | 193 | 0.290 |
Why?
|
Abortion, Spontaneous | 1 | 2022 | 539 | 0.290 |
Why?
|
Condoms | 2 | 2024 | 338 | 0.280 |
Why?
|
Resource Allocation | 1 | 2019 | 353 | 0.280 |
Why?
|
Birth Certificates | 2 | 2015 | 71 | 0.270 |
Why?
|
Mortality | 2 | 2019 | 2917 | 0.270 |
Why?
|
Schools | 3 | 2015 | 1496 | 0.270 |
Why?
|
Age Distribution | 6 | 2024 | 2881 | 0.270 |
Why?
|
Delivery of Health Care | 4 | 2018 | 5367 | 0.260 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2021 | 4049 | 0.260 |
Why?
|
Extramarital Relations | 1 | 2014 | 6 | 0.250 |
Why?
|
Public Assistance | 1 | 2015 | 47 | 0.250 |
Why?
|
Asia, Central | 1 | 2024 | 13 | 0.240 |
Why?
|
Achievement | 1 | 2016 | 288 | 0.240 |
Why?
|
AIDS Serodiagnosis | 2 | 2014 | 220 | 0.240 |
Why?
|
Europe, Eastern | 1 | 2024 | 72 | 0.240 |
Why?
|
Burkina Faso | 1 | 2024 | 88 | 0.240 |
Why?
|
Developed Countries | 2 | 2024 | 451 | 0.240 |
Why?
|
Uganda | 4 | 2023 | 1350 | 0.230 |
Why?
|
Goals | 2 | 2016 | 715 | 0.230 |
Why?
|
Software | 2 | 2019 | 4463 | 0.230 |
Why?
|
Urethral Diseases | 1 | 2024 | 52 | 0.230 |
Why?
|
Perception | 1 | 2021 | 1207 | 0.230 |
Why?
|
Health Services Accessibility | 7 | 2020 | 5510 | 0.230 |
Why?
|
Health Planning | 2 | 2012 | 233 | 0.230 |
Why?
|
Population Surveillance | 2 | 2016 | 2601 | 0.220 |
Why?
|
Life Expectancy | 2 | 2017 | 1249 | 0.220 |
Why?
|
Health Facilities | 1 | 2018 | 576 | 0.220 |
Why?
|
Program Development | 1 | 2019 | 1296 | 0.220 |
Why?
|
Health Services | 1 | 2018 | 756 | 0.210 |
Why?
|
Epidemiologic Methods | 2 | 2014 | 1337 | 0.210 |
Why?
|
Genital Diseases, Female | 1 | 2024 | 193 | 0.210 |
Why?
|
Health Resources | 2 | 2016 | 950 | 0.210 |
Why?
|
Population Groups | 1 | 2024 | 208 | 0.210 |
Why?
|
Vaginosis, Bacterial | 1 | 2024 | 151 | 0.200 |
Why?
|
Developing Countries | 2 | 2020 | 2901 | 0.200 |
Why?
|
Pandemics | 4 | 2021 | 8753 | 0.200 |
Why?
|
Health Services Needs and Demand | 2 | 2017 | 1408 | 0.200 |
Why?
|
Child Welfare | 2 | 2013 | 523 | 0.190 |
Why?
|
Zambia | 3 | 2021 | 273 | 0.190 |
Why?
|
Social Welfare | 1 | 2012 | 87 | 0.190 |
Why?
|
Government Programs | 1 | 2024 | 278 | 0.190 |
Why?
|
Cote d'Ivoire | 2 | 2021 | 65 | 0.180 |
Why?
|
Infertility, Female | 1 | 2017 | 764 | 0.180 |
Why?
|
Infertility | 1 | 2017 | 654 | 0.180 |
Why?
|
Africa, Southern | 2 | 2021 | 60 | 0.180 |
Why?
|
Unsafe Sex | 1 | 2012 | 239 | 0.180 |
Why?
|
Botswana | 1 | 2024 | 1059 | 0.180 |
Why?
|
Models, Biological | 4 | 2014 | 9505 | 0.170 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1282 | 0.170 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10358 | 0.170 |
Why?
|
Cohort Studies | 11 | 2022 | 41797 | 0.170 |
Why?
|
Patient Acceptance of Health Care | 3 | 2019 | 3237 | 0.170 |
Why?
|
Educational Status | 2 | 2014 | 2519 | 0.170 |
Why?
|
Age Factors | 7 | 2024 | 18478 | 0.170 |
Why?
|
Ownership | 1 | 2012 | 343 | 0.160 |
Why?
|
Poverty | 2 | 2019 | 2719 | 0.160 |
Why?
|
Refusal to Participate | 1 | 2009 | 30 | 0.160 |
Why?
|
Risk Factors | 15 | 2024 | 74915 | 0.160 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 26351 | 0.160 |
Why?
|
HIV-1 | 3 | 2019 | 6966 | 0.160 |
Why?
|
Health Care Costs | 3 | 2016 | 3265 | 0.160 |
Why?
|
Drug Resistance, Viral | 1 | 2013 | 869 | 0.150 |
Why?
|
Social Support | 2 | 2018 | 2195 | 0.150 |
Why?
|
Cluster Analysis | 4 | 2020 | 2731 | 0.150 |
Why?
|
Hepatitis B | 1 | 2014 | 707 | 0.150 |
Why?
|
Guideline Adherence | 1 | 2018 | 2239 | 0.150 |
Why?
|
Demography | 3 | 2018 | 1643 | 0.150 |
Why?
|
Forecasting | 4 | 2019 | 2950 | 0.150 |
Why?
|
World Health Organization | 3 | 2019 | 1328 | 0.150 |
Why?
|
Serologic Tests | 2 | 2019 | 383 | 0.140 |
Why?
|
Cost of Illness | 1 | 2016 | 1960 | 0.140 |
Why?
|
Child | 13 | 2024 | 80863 | 0.140 |
Why?
|
Seroepidemiologic Studies | 2 | 2023 | 406 | 0.140 |
Why?
|
Health Expenditures | 2 | 2024 | 2391 | 0.120 |
Why?
|
Survival Analysis | 4 | 2021 | 10125 | 0.120 |
Why?
|
Logistic Models | 5 | 2024 | 13324 | 0.120 |
Why?
|
Sex Distribution | 3 | 2016 | 2286 | 0.120 |
Why?
|
India | 3 | 2016 | 2323 | 0.120 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2518 | 0.120 |
Why?
|
Tanzania | 2 | 2021 | 1405 | 0.120 |
Why?
|
Primary Health Care | 1 | 2020 | 4737 | 0.110 |
Why?
|
Hepatitis C | 1 | 2014 | 1594 | 0.110 |
Why?
|
Child, Preschool | 8 | 2022 | 42623 | 0.110 |
Why?
|
Data Collection | 1 | 2012 | 3329 | 0.100 |
Why?
|
Survivors | 1 | 2013 | 2381 | 0.100 |
Why?
|
Stress, Psychological | 1 | 2018 | 4538 | 0.100 |
Why?
|
Herpesvirus 2, Human | 1 | 2023 | 191 | 0.100 |
Why?
|
Health Behavior | 1 | 2013 | 2649 | 0.100 |
Why?
|
Antiviral Agents | 1 | 2014 | 3063 | 0.090 |
Why?
|
Dietary Supplements | 1 | 2024 | 3445 | 0.090 |
Why?
|
Practice Guidelines as Topic | 2 | 2018 | 7451 | 0.090 |
Why?
|
Vaccination | 1 | 2013 | 3434 | 0.090 |
Why?
|
Malaria | 1 | 2020 | 1240 | 0.090 |
Why?
|
Health Promotion | 1 | 2012 | 2215 | 0.090 |
Why?
|
Sex Factors | 3 | 2021 | 10647 | 0.090 |
Why?
|
Mental Disorders | 1 | 2020 | 6879 | 0.090 |
Why?
|
Infant, Newborn | 5 | 2022 | 26395 | 0.090 |
Why?
|
China | 2 | 2016 | 2398 | 0.090 |
Why?
|
Safe Sex | 1 | 2020 | 144 | 0.090 |
Why?
|
Urban Population | 2 | 2018 | 2047 | 0.090 |
Why?
|
Americas | 1 | 2019 | 110 | 0.090 |
Why?
|
Mental Health | 1 | 2014 | 3271 | 0.080 |
Why?
|
Heterosexuality | 1 | 2022 | 309 | 0.080 |
Why?
|
Self Report | 2 | 2021 | 3771 | 0.080 |
Why?
|
Rwanda | 1 | 2022 | 669 | 0.080 |
Why?
|
Stillbirth | 1 | 2022 | 376 | 0.080 |
Why?
|
Drug Therapy, Combination | 3 | 2014 | 6320 | 0.080 |
Why?
|
Diagnostic Services | 1 | 2018 | 34 | 0.080 |
Why?
|
Personnel Management | 1 | 2018 | 54 | 0.080 |
Why?
|
Medication Adherence | 2 | 2022 | 2190 | 0.080 |
Why?
|
Family Characteristics | 2 | 2014 | 1002 | 0.080 |
Why?
|
Asia | 1 | 2019 | 627 | 0.070 |
Why?
|
Research Design | 1 | 2024 | 6217 | 0.070 |
Why?
|
Australia | 1 | 2021 | 1264 | 0.070 |
Why?
|
Secondary Prevention | 2 | 2014 | 1479 | 0.070 |
Why?
|
Disease Outbreaks | 2 | 2021 | 1764 | 0.070 |
Why?
|
Canada | 1 | 2022 | 2143 | 0.070 |
Why?
|
Marital Status | 1 | 2018 | 426 | 0.070 |
Why?
|
Sex Ratio | 1 | 2017 | 107 | 0.070 |
Why?
|
Aged | 9 | 2021 | 171520 | 0.070 |
Why?
|
Public Health | 2 | 2021 | 2693 | 0.070 |
Why?
|
Social Class | 2 | 2016 | 2000 | 0.070 |
Why?
|
False Positive Reactions | 1 | 2019 | 962 | 0.070 |
Why?
|
Disclosure | 1 | 2022 | 750 | 0.070 |
Why?
|
Birth Rate | 1 | 2017 | 168 | 0.060 |
Why?
|
England | 1 | 2016 | 533 | 0.060 |
Why?
|
Contraception | 1 | 2018 | 362 | 0.060 |
Why?
|
Professional Practice | 1 | 2017 | 314 | 0.060 |
Why?
|
Chlamydia trachomatis | 1 | 2016 | 239 | 0.060 |
Why?
|
Divorce | 1 | 2014 | 78 | 0.060 |
Why?
|
Databases as Topic | 1 | 2016 | 475 | 0.060 |
Why?
|
Health Plan Implementation | 1 | 2017 | 338 | 0.060 |
Why?
|
Databases, Factual | 2 | 2019 | 8081 | 0.060 |
Why?
|
Time Factors | 4 | 2018 | 40271 | 0.050 |
Why?
|
Ambulatory Care Facilities | 1 | 2019 | 941 | 0.050 |
Why?
|
Diagnostic Tests, Routine | 1 | 2019 | 792 | 0.050 |
Why?
|
Vietnam | 1 | 2013 | 416 | 0.050 |
Why?
|
Marriage | 1 | 2014 | 352 | 0.050 |
Why?
|
Propensity Score | 1 | 2020 | 1971 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4861 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
Infant | 4 | 2017 | 36497 | 0.050 |
Why?
|
Prenatal Diagnosis | 1 | 2019 | 1274 | 0.050 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7863 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Diffusion of Innovation | 1 | 2017 | 730 | 0.050 |
Why?
|
Triage | 1 | 2019 | 997 | 0.050 |
Why?
|
Politics | 1 | 2018 | 821 | 0.050 |
Why?
|
Censuses | 1 | 2012 | 198 | 0.050 |
Why?
|
Poverty Areas | 1 | 2012 | 265 | 0.050 |
Why?
|
Computer Simulation | 2 | 2016 | 6278 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14766 | 0.050 |
Why?
|
Risk Assessment | 3 | 2018 | 24311 | 0.040 |
Why?
|
Students | 1 | 2020 | 1751 | 0.040 |
Why?
|
Regression Analysis | 1 | 2019 | 6353 | 0.040 |
Why?
|
Eligibility Determination | 1 | 2013 | 420 | 0.040 |
Why?
|
Travel | 1 | 2015 | 800 | 0.040 |
Why?
|
Deoxycytidine | 1 | 2013 | 888 | 0.040 |
Why?
|
Body Height | 1 | 2014 | 1568 | 0.040 |
Why?
|
Attitude to Health | 1 | 2017 | 2030 | 0.040 |
Why?
|
Adenine | 1 | 2013 | 993 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2022 | 81834 | 0.040 |
Why?
|
Health Status | 1 | 2021 | 4096 | 0.040 |
Why?
|
Empathy | 1 | 2012 | 476 | 0.040 |
Why?
|
Residence Characteristics | 1 | 2017 | 2119 | 0.040 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1813 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2012 | 2932 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4419 | 0.030 |
Why?
|
Urban Health | 1 | 2009 | 535 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12096 | 0.030 |
Why?
|
Cause of Death | 1 | 2016 | 3727 | 0.030 |
Why?
|
Prospective Studies | 2 | 2022 | 54914 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2016 | 59680 | 0.030 |
Why?
|
Health Personnel | 1 | 2018 | 3384 | 0.030 |
Why?
|
Virus Diseases | 1 | 2020 | 723 | 0.030 |
Why?
|
Disease Progression | 1 | 2021 | 13655 | 0.030 |
Why?
|
Income | 1 | 2013 | 1878 | 0.030 |
Why?
|
Body Weight | 1 | 2014 | 4630 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3922 | 0.030 |
Why?
|
Patient Compliance | 1 | 2013 | 2696 | 0.030 |
Why?
|
Risk | 1 | 2014 | 9642 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15460 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2016 | 3412 | 0.020 |
Why?
|
Odds Ratio | 1 | 2012 | 9687 | 0.020 |
Why?
|
Chronic Disease | 1 | 2015 | 9382 | 0.020 |
Why?
|
Algorithms | 1 | 2019 | 14158 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2014 | 65409 | 0.020 |
Why?
|
United States | 1 | 2020 | 73121 | 0.010 |
Why?
|
Concepts
(256)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_